TY  - JOUR 
AU  - Lima-Posada, Ixchel
AU  - Stephan, Yohan
AU  - Soulié, Matthieu
AU  - Bonnard, Benjamin
AU  - Nicol, Lionel
AU  - Kolkhof, Peter
AU  - Jaisser, Frederic
AU  - Mulder, Paul
AU  - Palacios-Ramirez, Roberto
PY  - 2023
UR  - https://uvadoc.uva.es/handle/10324/65924
AB  - The mineralocorticoid receptor (MR) plays an important role in the development of chronic kidney disease (CKD) and associated cardiovascular complications. Antagonizing the overactivation of the MR with MR antagonists (MRA) is a therapeutic option,...
LA  - eng
KW  - diabetes; heart failure; mineralocorticoid receptor antagonist; diastolic dysfunction; finerenone
TI  - Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction
DO  - 10.3390/ijms24032536
ER  -